Mary Lovely, professor of economics in the Maxwell School, was quoted by Business Insider for the story “The government is raking in billions of dollars from Trump’s tariffs.”
Research, development and marketing of prescription drugs topic of next Frontiers of Science Lecture
Research, development and marketing of prescription drugs topic of next Frontiers of Science LectureOctober 11, 2001Judy Holmesjlholmes@syr.edu
David Dodds, director of fermentation and biocatalysis development at Bristol-Myers Squibb, will present “Pharmaceuticals: How the Race is Run” at 7:30 p.m. Oct. 24 in Syracuse University’s Gifford Auditorium in Huntington Beard Crouse. The lecture, part of the continuing Frontiers of Science Lecture Series, is free and open to the public.
The high cost of medication and the time it takes to bring a medication to the market has received increased public interest during the last few years. While the answers are not straightforward, the pharmaceutical industry is continuously looking at ways to improve the process and bring life-saving medications to the market.
Dodds is a career scientist with experience working in both small and large pharmaceutical companies. He has extensive experience in drug development and will provide an overview of the process of bringing a medication to the market.
The Frontiers of Science Lecture Series is sponsored by SU’s departments of Science Teaching, Biology, Chemistry, Earth Sciences, Mathematics and Physics in The College of Arts and Sciences, the L.C. Smith College of Engineering and Computer Science, the School of Education, the SUNY College of Environmental Science and Forestry and several community organizations. The series is designed to increase public awareness of advances in science and to stimulate thought and discussion about the moral, ethical and societal implications of the advances.